Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04534946 · ClinicalTrials.gov registry record
A Pilot Study Evaluating the Usability of the Oabi Mobile Application
A clinical trial of Overactive Bladder, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 35
- Enrollment target
- 1
- Study location
NCT04534946: Completed study of Overactive Bladder, sponsored by Massachusetts General Hospital.
NCT04534946 is a study of Overactive Bladder that has completed, run by Massachusetts General Hospital. The registered enrollment target is 35 participants, below the 207-participant average among 46 other Overactive Bladder trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04534946, a study of Overactive Bladder, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 35 participants
- Enrollment target
- 1
- Study location
Study Summary
Our primary purpose is to assess the use feasibility and acceptability of the study phone app called, "Oabi" app with patients diagnosed with overactive bladder disorder (OAB).
Primary Outcome
To assess the usability and acceptability of the mobile app via post-pilot survey
Conditions Studied
Interventions
- OTHER This is not an intervention study
Study Locations (1)
Massachusetts
- Mass General/North Shore Center - Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2017-03-20 |
| Est. Completion | 2019-12-31 |
What the finished NCT04534946 record still lists
NCT04534946 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 207-participant average among 46 other Overactive Bladder trials with a reported enrollment target (83% lower).
The record links to 1 condition, with Overactive Bladder appearing as the primary indexed condition, and to 1 intervention - of which This is not an intervention study is the first listed.
NCT04534946 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04534946 about?
NCT04534946 is a clinical study titled "A Pilot Study Evaluating the Usability of the Oabi Mobile Application". Our primary purpose is to assess the use feasibility and acceptability of the study phone app called, "Oabi" app with patients diagnosed with overactive bladder disorder (OAB).
What is the current status of trial NCT04534946?
This trial is currently completed. The enrollment target is 35 participants. The study started on 2017-03-20. Estimated completion is 2019-12-31.
What conditions does trial NCT04534946 study?
This clinical trial studies the following conditions: Overactive Bladder.
What interventions are being tested in trial NCT04534946?
The interventions under investigation include: This is not an intervention study (OTHER).
Who is sponsoring clinical trial NCT04534946?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04534946 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Overactive Bladder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04534946's enrollment target sits among peer trials
35 35th of 46 higher than 12 of 46 other Overactive Bladder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Overactive Bladder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Home Versus Office Removal of Percutaneous Nerve Evaluation (PNE) Lead
RECRUITING · NA
-
Bladder Botox UTI Antibiotic Prophylaxis
RECRUITING · Phase 4
-
Percutaneous Nerve Evaluation Trial Time
RECRUITING · NA
-
Noninvasive Ultrasound Assessment of Detrusor Dysfunction
RECRUITING
-
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
RECRUITING · NA
-
Neuromodulating Cortical Regions Involved in Neurogenic Bladder in MS
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI